Skip to main content
CRBU
NASDAQ Life Sciences

Caribou's Vispa-cel Shows 82% ORR, Advances to Phase 3; CB-011 Hits 92% ORR in Follow-up

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
9
Price
$1.81
Mkt Cap
$177.533M
52W Low
$1.04
52W High
$3.535
52W Position info
74% above low
Off High info
49% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CRBU sits 74% above its 52-week low of $1.04.

Summary

Caribou Biosciences reported strong Phase 1 follow-up data for two key allogeneic CAR-T cell therapies, with manageable safety profiles. Vispa-cel achieved an 82% Overall Response Rate (ORR) and 67% Complete Response (CR) in 2L LBCL, with a 17.1-month median PFS. Separately, CB-011 showed a 92% ORR and 83% complete response or better in BCMA-naïve patients. This positive clinical data significantly de-risks the company's pipeline, especially with vispa-cel's Phase 3 trial design now aligned with the FDA. This builds on the FDA RMAT designation CB-011 received in March. The company is scheduled to present vispa-cel data at EHA on June 12 and CB-011 data on June 14.

At the time of this announcement, CRBU was trading at $1.81 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $177.5M. The 52-week trading range was $1.04 to $3.54. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

CRBU - Latest Insights

CRBU
Nov 05, 2026, 4:08 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.3081 info
Change: -$0.0969 (-24%) info
Market Cap: $33.545M info
CRBU
Nov 05, 2026, 4:07 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.405
Real-time Price: $0.3081 info
Change: -$0.0969 (-24%) info
Market Cap: $33.545M info
CRBU
Oct 06, 2026, 4:37 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $0.705
Real-time Price: $0.3081 info
Change: -$0.3969 (-56%) info
Market Cap: $33.545M info
CRBU
Oct 06, 2026, 4:11 PM EDT
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.3081 info
Change: -$0.8269 (-73%) info
Market Cap: $33.545M info
CRBU
Oct 06, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.14
Real-time Price: $0.3081 info
Change: -$0.8269 (-73%) info
Market Cap: $33.545M info